Harnessing AI for Clinical Trial Workflow Management

Abraham Gutman, CEO and Founder, AG Mednet

Abraham Gutman founded AG Mednet in 2005 after selling his previous company to AT&T. He is a technologist with 35 years of experience in the conception, implementation and sales of advanced software systems and platforms in fields including telecommunications and life sciences. He holds a BA in Computer Science from Cornell and an MS in Computer Science (AI) from Yale.

Catherine Tyner, Executive Director, Adjudication Services, Fortrea

Catherine Tyner, MA, MFA, ABD, is the Executive Director of Adjudication Services at Fortrea with over 26 years of clinical research experience. Her expertise predominantly lies in Oversight Group Management (CECs, DSMBs/DMCs), Core Laboratories, and Clinical Safety where she has made significant contributions to shaping the industry.

Throughout her career, Catherine has led the establishment and global leadership of Adjudication departments at renowned organizations such as Quintiles, Novella Clinical, and Covance (now Fortrea). With oversight of 300+ Adjudication trials across diverse therapeutic areas, she has contributed to shaping the industry’s approach to Adjudication.

Catherine was an early advocate of electronic adjudication and has provided crucial advisory insights for the development of Adjudication technology solutions. Her notable publications, conference contributions, and her seminal 2011 white paper titled “Establishment and Operation of Clinical Endpoint Committees: Best Practice for Implementation Across the Biopharmaceutical Industry” underscore her thought leadership and contributions to the body of clinical research knowledge and best practice.

Kimberly J. Brown, RN, BSN

Kimberly J. Brown has been a Registered Nurse for 40 years. She has worked in cardiology ICU and stepdowns at the Cleveland Clinic in Cleveland Ohio from 1983 to 1996. In 1996, she moved to Anchorage Alaska to help Columbia Hospitals start an Open-Heart Surgery program. She was also the Director of Critical Care there overseeing the ICU, Stepdown, ER, Cath and EP Labs. In 1998, she returned to the Cleveland Clinic and worked as an Adult and Pediatric Cardiology Clinical Trials Research Coordinator. Transitioned to C5 Research and worked as a Clinical Trials Project Manager. For the last 15 years, she has worked as the Manager of the Adjudication Group within C5 Research. During this time, she oversaw the completion of adjudication for more than 180 pharmaceutical and device trials. She co-authored multiple research abstracts, manuscripts and a book chapter during her career. She also has presented at multiple international conferences on cardiac nursing and research topics.

Venugopal Menon, MD, FACC, FAHA, Section Head of Clinical Cardiology, Robert and Suzanne Tomisch Department of Cardiovascular Medicine, Sydell and Arnold Miller Family Heart, Vascular & Thoracic Institute

Dr. Venu Menon is the Section Head of Clinical Cardiology in the Robert and Suzanne Tomisch Department of Cardiovascular Medicine, Sydell and Arnold Miller Family Heart, Vascular & Thoracic Institute. He is also the Director of the Cardiac Intensive Care Unit and the Cardiovascular Fellowship program and is the Mehdi Razavi Endowed Chair and Professor of Medicine at the Cleveland Clinic Lerner College of Medicine.

Dr. Menon has published more than 200 manuscripts in peer-reviewed publications with research interests in cardiac critical care and time-sensitive cardiac emergencies. Dr. Menon also has a leadership position in the Cleveland Clinic Clinical Coordinating Center for Clinical Research (C5 Research) and is involved in the conduct of clinical trials around the world, including chairmanship of the cardiovascular events committee on multiple phase III seminal clinical trials. He serves on the American Heart Association committee for scientific sessions and is the American College of Cardiology Liaison to the American Heart Association’s Emergency Cardiovascular Care committee.